Putignani L, Del Chierico F, Petrucca A, Vernocchi P, Dallapiccola B
04/03/2024 Ja tinha comprado o artigo antes e voltei a comprar por causa do preo e da facil deglutiao do produto
doi: 10.1371/journal.pone.0231136 389 NguyenTStainesDJohnstonSMarshall-GradisnikS
Landmark Nature and Impact: The SELECT trial (2015) showed that GLP-1 drugs not only reduce weight but also lower cardiovascular risks a game changer in metabolic medicine with potential implications for brain health and neurodegeneration
Although the precise mechanisms responsible for the accelerated atherosclerosis are not fully understood, it has been shown that endothelial dysfunction is one of the earliest events in the development of atherosclerosis
PubMed Hutter-Paier, B., Grygar, E., Windisch, M., & Skofitsch, G